Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding - PubMed (original) (raw)
Comparative Study
. 2004 Mar 1;64(5):1886-92.
doi: 10.1158/0008-5472.can-03-2424.
Kevin D Judy, Isolde Dunphy, W Timothy Jenkins, Peter T Nelson, Ruth Collins, E Paul Wileyto, Kevin Jenkins, Stephen M Hahn, Craig W Stevens, Alexander R Judkins, Peter Phillips, Birgit Geoerger, Cameron J Koch
Affiliations
- PMID: 14996753
- DOI: 10.1158/0008-5472.can-03-2424
Comparative Study
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding
Sydney M Evans et al. Cancer Res. 2004.
Abstract
Hypoxia is known to be an important prognostic marker in many human cancers. We report the use of two oxygen measurement techniques in human brain tumors and compare these data with semiquantitative histological end points. Oxygenation was measured using the Eppendorf needle electrode and/or EF5 binding in 28 brain tumors. These data were compared with necrosis, mitosis, and endothelial proliferation. In some tumors, absolute EF5 binding was converted to tissue pO(2) based on in vitro calibrations. Eppendorf electrode readings could not be used to identify WHO grade 1/2 versus WHO grade 3/4 tumors, they could not differentiate grade 3 versus grade 4 glial-derived neoplasms, nor did they correlate with necrosis or endothelial proliferation scores. EF5 binding increased as the tumor grade increased and was significantly associated with necrosis and endothelial proliferation. There was no statistically significant correlation between the two hypoxia detection techniques, although both methods indicated similar absolute ranges of tissue pO(2). There was substantial inter- and intratumoral heterogeneity of EF5 binding in WHO grade 4 glial neoplasms. The majority of cells in glial-derived tumor had levels of hypoxia that were mild to moderate (defined herein as 10% to 0.5% pO(2)) rather than severe (defined as approximately 0.1% pO(2)). Immunohistochemical detection of EF5 binding tracks histological parameters in adult brain tumors, with increased binding associated with increasing necrosis and endothelial proliferation. The proportion of moderately to severely hypoxic cells is relatively low, even in the high-grade tumors. Human brain tumors are dominated by oxic to moderately hypoxic cells.
Similar articles
- Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
Jenkins WT, Evans SM, Koch CJ. Jenkins WT, et al. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):1005-17. doi: 10.1016/s0360-3016(99)00342-9. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705024 - Hypoxia is important in the biology and aggression of human glial brain tumors.
Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, Koch CJ. Evans SM, et al. Clin Cancer Res. 2004 Dec 15;10(24):8177-84. doi: 10.1158/1078-0432.CCR-04-1081. Clin Cancer Res. 2004. PMID: 15623592 - Hypoxia in human intraperitoneal and extremity sarcomas.
Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, Hsi RA, McKenna WG, Koch CJ. Evans SM, et al. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):587-96. doi: 10.1016/s0360-3016(00)01494-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173159 Clinical Trial. - Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5.
Koch CJ. Koch CJ. Methods Enzymol. 2002;352:3-31. doi: 10.1016/s0076-6879(02)52003-6. Methods Enzymol. 2002. PMID: 12125356 Review. - Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.
Koch CJ, Evans SM. Koch CJ, et al. Adv Exp Med Biol. 2003;510:285-92. doi: 10.1007/978-1-4615-0205-0_47. Adv Exp Med Biol. 2003. PMID: 12580442 Review.
Cited by
- Automated glioblastoma patient classification using hypoxia levels measured through magnetic resonance images.
Shahram MA, Azimian H, Abbasi B, Ganji Z, Khadem-Reza ZK, Khakshour E, Zare H. Shahram MA, et al. BMC Neurosci. 2024 May 25;25(1):26. doi: 10.1186/s12868-024-00871-2. BMC Neurosci. 2024. PMID: 38789970 Free PMC article. - Flavonoids as Potential Natural Compounds for the Prevention and Treatment of Eczema.
Khan J, Yadav S, Bhardwaj D, Kumar A, Okanlawon MU. Khan J, et al. Antiinflamm Antiallergy Agents Med Chem. 2024;23(2):71-84. doi: 10.2174/0118715230299752240310171954. Antiinflamm Antiallergy Agents Med Chem. 2024. PMID: 38721791 Review. - Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models.
Lee TW, Singleton DC, Harms JK, Lu M, McManaway SP, Lai A, Tercel M, Pruijn FB, Macann AMJ, Hunter FW, Wilson WR, Jamieson SMF. Lee TW, et al. Mol Oncol. 2024 Aug;18(8):1885-1903. doi: 10.1002/1878-0261.13620. Epub 2024 Mar 1. Mol Oncol. 2024. PMID: 38426642 Free PMC article. - Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach.
Bayona C, Alza L, Ranđelović T, Sallán MC, Visa A, Cantí C, Ochoa I, Oliván S, Herreros J. Bayona C, et al. Cell Death Dis. 2024 Feb 10;15(2):127. doi: 10.1038/s41419-024-06492-1. Cell Death Dis. 2024. PMID: 38341408 Free PMC article. - Effects of C10orf10 on growth and prognosis of glioma under hypoxia.
Chen Y, Tang M, Li H, Huang J. Chen Y, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Apr 28;48(4):499-507. doi: 10.11817/j.issn.1672-7347.2023.220396. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37385612 Free PMC article. Chinese, English.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical